Evidence map›Paper›PMID 20425541›Full record

ReviewSurgery today2010

Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer).

Kiyoshi Yoshimura, Kelly Olino, Barish H Edil, Richard D Schulick, Masaaki Oka

Abstract readReview
PubMed Publisher
In one paragraph

Review in Surgery today, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Kiyoshi YoshimuraDepartment of Surgery II, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan.
Kelly Olino
Barish H Edil
Richard D Schulick
Masaaki Oka
Johns Hopkins University · USYamaguchi University · JPJohns Hopkins Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current treatment modalities of surgical resection and chemotherapy against cancers have improved survival. However, mortality from tumor recurrence remains high. Immunotherapy and gene therapy are potential additions to the treatment arsenal in the care of cancer patients. These novel therapeutic approaches need further investigation in in vitro and in vivo models as they are developed for potential use in humans. Here we reviewed immunotherapies and gene therapies that included clinical trials against cancers (mainly focusing on pancreatic cancer) suggesting the strong possibility of using these novel approaches.

Indexed as

AnimalsCancer VaccinesCarcinoma, Pancreatic DuctalClinical Trials as TopicDisease Models, AnimalGenetic TherapyHumansImmunotherapyNeoplasm Recurrence, LocalNeoplasmsPancreatic NeoplasmsCancer Vaccines

Identifiers

PMID20425541
OpenAlexW2030101653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.